Yellow Fever Vaccination of Human Immunodeficiency Virus-Infected Patients: Report of 2 Cases
Clinical Infectious Diseases2000Vol. 31(3), pp. e7–e8
Citations Over TimeTop 10% of 2000 papers
Abstract
Yellow fever vaccine (17D, a live attenuated virus vaccine) was effective and safe in 2 human immunodeficiency virus-infected patients without severe immunosuppression, one of whom traveled to Kenya and the other of whom traveled to Senegal.
Related Papers
- → Yellow Fever–Associated Viscerotropic Disease in Barcelona, Spain(2008)29 cited
- → Single shot of 17D vaccine may not confer life-long protection against yellow fever(2017)18 cited
- → Is the yellow fever vaccine safe?(2001)1 cited
- → Present situation and progress in yellow fever attenuated live vaccine(2018)
- [Yellow fever].(2004)